Crocs, Inc. (CROX) Analysts See $0.16 EPS; Nanoviricides (NNVC) Sentiment Is 1.33

July 17, 2017 - By Richard Conner

Analysts expect Crocs, Inc. (NASDAQ:CROX) to report $0.16 EPS on August, 2.They anticipate $0.03 EPS change or 23.08% from last quarter’s $0.13 EPS. CROX’s profit would be $11.80M giving it 11.86 P/E if the $0.16 EPS is correct. After having $0.11 EPS previously, Crocs, Inc.’s analysts see 45.45% EPS growth. About 662,015 shares traded. Crocs, Inc. (NASDAQ:CROX) has declined 28.43% since July 17, 2016 and is downtrending. It has underperformed by 45.13% the S&P500.

NanoViricides, Inc. is a nano-biopharmaceutical company. The company has market cap of $90.57 million. The Firm is a development-stage firm with several drugs in various stages of development. It currently has negative earnings. The Firm focuses on its research and clinical programs on specific anti-viral therapeutics.

Crocs, Inc. is engaged in the design, development, manufacturing, marketing, distribution and sale of casual lifestyle footwear and accessories for men, women, and children. The company has market cap of $559.70 million. The Company’s divisions include Americas, Asia Pacific and Europe. It currently has negative earnings. The Company’s products include footwear and accessories that utilize its closed-cell resin, called Croslite, as well as casual lifestyle footwear that use a range of materials.

Investors sentiment decreased to 1.11 in 2016 Q4. Its down 0.14, from 1.25 in 2016Q3. It is negative, as 22 investors sold Crocs, Inc. shares while 43 reduced holdings. 27 funds opened positions while 45 raised stakes. 66.13 million shares or 0.58% less from 66.51 million shares in 2016Q3 were reported. Aperio Ltd Liability Corp holds 18,356 shares or 0% of its portfolio. Hsbc Holdg Pcl holds 31,720 shares or 0% of its portfolio. Moreover, Pinebridge Invs L P has 0.01% invested in Crocs, Inc. (NASDAQ:CROX). State Of Alaska Department Of Revenue stated it has 7,950 shares or 0.01% of all its holdings. Deutsche Bankshares Ag has invested 0% in Crocs, Inc. (NASDAQ:CROX). Panagora Asset Management accumulated 0% or 645 shares. Invesco Limited invested in 225,204 shares. Profit Inv Management Ltd holds 0.9% or 139,209 shares. The Ontario – Canada-based Retail Bank Of Montreal Can has invested 0% in Crocs, Inc. (NASDAQ:CROX). Sei Investments has invested 0% of its portfolio in Crocs, Inc. (NASDAQ:CROX). Tower Research Capital Limited Co (Trc) has invested 0% in Crocs, Inc. (NASDAQ:CROX). Inv Counselors Of Maryland Lc owns 678,695 shares or 0.25% of their US portfolio. Howe & Rusling Incorporated accumulated 145 shares. Ironwood Inv Mgmt Ltd Liability Company stated it has 46,297 shares or 0.23% of all its holdings. First Tru Advsrs Limited Partnership reported 0% of its portfolio in Crocs, Inc. (NASDAQ:CROX).

Among 7 analysts covering Crocs (NASDAQ:CROX), 1 have Buy rating, 0 Sell and 6 Hold. Therefore 14% are positive. Crocs had 14 analyst reports since August 11, 2015 according to SRatingsIntel. The stock of Crocs, Inc. (NASDAQ:CROX) earned “Buy” rating by Stifel Nicolaus on Thursday, October 1. The firm earned “Neutral” rating on Thursday, November 10 by Monness Crespi & Hardt. Piper Jaffray maintained Crocs, Inc. (NASDAQ:CROX) rating on Thursday, July 13. Piper Jaffray has “Hold” rating and $700 target. Susquehanna initiated Crocs, Inc. (NASDAQ:CROX) rating on Friday, August 12. Susquehanna has “Neutral” rating and $9.50 target. Sterne Agee CRT downgraded Crocs, Inc. (NASDAQ:CROX) on Tuesday, October 27 to “Neutral” rating. As per Tuesday, August 11, the company rating was maintained by Piper Jaffray. As per Thursday, October 1, the company rating was maintained by B. Riley & Co. Sterne Agee CRT maintained Crocs, Inc. (NASDAQ:CROX) on Friday, August 14 with “Buy” rating. As per Wednesday, April 27, the company rating was downgraded by Stifel Nicolaus. The firm has “Neutral” rating by Piper Jaffray given on Thursday, October 1.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.